YIM TACKETT: Open Payments
NPI 1346699329 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 66 payments from 15 companies in 2025. Trend: 2023 $1,359 · 2024 $1,763 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $175 |
| Actelion Pharmaceuticals US, Inc. | 7 | $166 |
| Amgen Inc. | 9 | $152 |
| Novo Nordisk Inc | 6 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $145 |
| Esperion Therapeutics, Inc. | 6 | $103 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $91 |
| PFIZER INC. | 4 | $80 |
| Alnylam Pharmaceuticals Inc. | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
Products named: REPATHA, Kerendia, VERQUVO, NEXLETOL, Wegovy, LifeVest, ELIQUIS, AMVUTTRA.
Industry payments across MS — which companies pay providers there.
